U.S. FDA: Tobacco Product Listings Must Be Regularly Updated, June 30 Marks Key Deadline

Jun.25
U.S. FDA: Tobacco Product Listings Must Be Regularly Updated, June 30 Marks Key Deadline
The U.S. FDA requires all registered tobacco manufacturers to submit product listing change reports by June 30 and December 31 each year. This includes new product launches, product discontinuations, resumptions of production, and significant changes to product information. Reports can be submitted online through the next-generation Tobacco Registration and Listing Module (TRLM NG) system or by mailing paper forms.

Key Points:

 

·Mandatory reporting frequency: June 30th and December 31st every year.

 

·Types of changes to report: new product launch, product discontinued or resumed, significant changes in product information.

 

Submission method:

 

·Preferred: Tobacco Registration and Listing Module for the Next Generation (TRLM NG) online system;

 

·Alternate option: Mail the FDA 3741/3741a form.

 

Prohibited actions: Do not submit duplicate information that has already been reported.

 

Target audience: All tobacco product manufacturers registered with the FDA.

 


 

On June 24, the U.S. Food and Drug Administration (FDA) stated that registered tobacco product manufacturers must report any changes in their tobacco product lists twice a year (June 30 and December 31) to the FDA.

 

Any changes made by the manufacturer must be reported.

 

·Introduced any tobacco products for commercial distribution that were not previously included on the list; 

·Ceased production, preparation, blending, or processing of any tobacco products for commercial distribution; 

·Resumed production, preparation, blending, or processing of any tobacco products previously listed as discontinued; 

·Made significant changes to any previously submitted listing information, such as name, label, consumer information, or advertising changes. 

·Information previously submitted to the FDA should not be resubmitted.

 

Updates can be submitted using the new Tobacco Registration and Listing Module Next Generation (TRLM NG). If applicants are unable to submit online using TRLM NG, they can mail the corresponding registration and listing PDF forms (FDA Form 3741 or FDA Form 3741a) to the Document Control Center at the Center for Tobacco Products (CTP).

 

For resources related to submitting a product list, please visit the Tobacco Registration and Listing - Next Generation (TRLM NG) information page. Manufacturers can also refer to the Registration and Product Listing page for domestic product owners and operators to learn more.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”
B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”
British Columbia, Canada is advancing what it calls the world’s first e-cigarette Public Health Accountability law, granting the government authority to sue companies for “deceptive marketing.” The move puts public-health risks at the center of vaping industry compliance.
Oct.10 by 2FIRSTS.ai
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
The Oregon Supreme Court prepares to review a case challenging restrictions on e-cigarette product descriptions, impacting small businesses and consumers.
Sep.22 by 2FIRSTS.ai
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
2Firsts provides exclusive coverage of Inter Tabac 2025, capturing new tobacco products and industry trends for readers.
Sep.18 by 2FIRSTS.ai
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.
Oct.13
Imperial Tobacco Canada announced the completion of settlement litigation, warning that the black market for tobacco could impact compensation funds
Imperial Tobacco Canada announced the completion of settlement litigation, warning that the black market for tobacco could impact compensation funds
Imperial Tobacco Canada announced the end of all related litigation as the court-approved settlement plan took effect. The company warned that Canada’s illegal tobacco market, now over 30% of total sales and growing, threatens the compensation plan’s sustainability. Legal sales revenues are crucial for funding annual payments to claimants.
Sep.01 by 2FIRSTS.ai
Company | PMI Wins Case Against FDA: Graphic Cigarette Warning Rule Vacated
Company | PMI Wins Case Against FDA: Graphic Cigarette Warning Rule Vacated
A federal court in the Southern District of Georgia has vacated the FDA’s final rule on graphic warnings for cigarette packages and advertisements. The court found the rule did not violate the Family Smoking Prevention and Tobacco Control Act (TCA) but was unlawful on procedural grounds for failing to disclose key underlying data. The plaintiffs included Philip Morris USA and the Georgia Association of Convenience Stores.
Sep.04 by 2FIRSTS.ai